Azacitidine Mylan União Europeia - croata - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Preductal MR 35 mg tablete s prilagođenim oslobađanjem Croácia - croata - HALMED (Agencija za lijekove i medicinske proizvode)

preductal mr 35 mg tablete s prilagođenim oslobađanjem

servier pharma d.o.o., tuškanova 37, zagreb, hrvatska - trimetazidindiklorid - tableta s prilagođenim oslobađanjem - 35 mg - urbroj: jedna tableta s prilagođenim oslobađanjem sadržava 35 mg trimetazidindiklorida

Dovprela (previously Pretomanid FGK) União Europeia - croata - EMA (European Medicines Agency)

dovprela (previously pretomanid fgk)

mylan ire healthcare limited - pretomanid - tuberkuloza, višestruko otporna - antimikobakterija - dovprela is indicated in combination with bedaquiline and linezolid, in adults, for the treatment of pulmonary extensively drug resistant (xdr), or treatment-intolerant or nonresponsive multidrug-resistant (mdr) tuberculosis (tb). treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.